Loading clinical trials...
Loading clinical trials...
Assessment of the Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19
Observational study of patients with End Stage Kidney Disease on dialysis and Kidney Transplant Recipients, before and after vaccination for SARS-COV 2, after written consent, with the aim of laboratory efficacy of the vaccine and safety regarding the clinical outcome of patients and possible complications.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
Evangelia Ntounousi
Ioannina, Epirus, Greece
Start Date
April 24, 2021
Primary Completion Date
December 1, 2021
Completion Date
March 1, 2023
Last Updated
September 29, 2021
100
ESTIMATED participants
SARS - COV 2 VACCINE
BIOLOGICAL
Lead Sponsor
University of Ioannina
NCT07271420
NCT05525507
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions